1. Home
  2. FEMY vs MITQ Comparison

FEMY vs MITQ Comparison

Compare FEMY & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • MITQ
  • Stock Information
  • Founded
  • FEMY 2004
  • MITQ N/A
  • Country
  • FEMY United States
  • MITQ United States
  • Employees
  • FEMY N/A
  • MITQ N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • MITQ Telecommunications Equipment
  • Sector
  • FEMY Health Care
  • MITQ Telecommunications
  • Exchange
  • FEMY Nasdaq
  • MITQ Nasdaq
  • Market Cap
  • FEMY 12.5M
  • MITQ 13.4M
  • IPO Year
  • FEMY 2021
  • MITQ 2021
  • Fundamental
  • Price
  • FEMY $0.60
  • MITQ N/A
  • Analyst Decision
  • FEMY Strong Buy
  • MITQ
  • Analyst Count
  • FEMY 3
  • MITQ 0
  • Target Price
  • FEMY $7.33
  • MITQ N/A
  • AVG Volume (30 Days)
  • FEMY 6.9M
  • MITQ 675.3K
  • Earning Date
  • FEMY 11-11-2025
  • MITQ 11-13-2025
  • Dividend Yield
  • FEMY N/A
  • MITQ N/A
  • EPS Growth
  • FEMY N/A
  • MITQ N/A
  • EPS
  • FEMY N/A
  • MITQ N/A
  • Revenue
  • FEMY $1,887,016.00
  • MITQ $18,147,000.00
  • Revenue This Year
  • FEMY $103.55
  • MITQ N/A
  • Revenue Next Year
  • FEMY $148.13
  • MITQ N/A
  • P/E Ratio
  • FEMY N/A
  • MITQ N/A
  • Revenue Growth
  • FEMY 98.61
  • MITQ N/A
  • 52 Week Low
  • FEMY $0.31
  • MITQ $0.50
  • 52 Week High
  • FEMY $1.80
  • MITQ $1.66
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 59.98
  • MITQ 45.08
  • Support Level
  • FEMY $0.34
  • MITQ $0.91
  • Resistance Level
  • FEMY $0.92
  • MITQ $1.07
  • Average True Range (ATR)
  • FEMY 0.06
  • MITQ 0.12
  • MACD
  • FEMY 0.05
  • MITQ -0.04
  • Stochastic Oscillator
  • FEMY 50.50
  • MITQ 6.85

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: